Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Biovail's Brexidol receives Canadian marketing approval

March 16, 1999

Novel sublingual apomorphine: efficacy and tolerability in fluctuating Parkinson's disease

March 16, 1999

Effexor XR receives FDA approval for treatment of GAD

March 15, 1999

GABA-A receptor ligands from MS&D for Alzheimer's disease

March 15, 1999

N-type calcium channel inhibitors described by Ono

March 15, 1999

Orally active analgesic agents in development at Otsuka

March 15, 1999

GABA-A alpha5 subunit-selective inverse agonists from Merck useful for Alzheimer's disease

March 12, 1999

Kynurenine 3-monooxygenase inhibitors for neurodegenerative disorders

March 12, 1999

Repligen to develop novel treatment for autism; clinical trials slated to begin this year

March 11, 1999

Novel class of GABA-A receptor ligands for cognitive disorders from Merck

March 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...